Chronic inflammation is postulated to be involved in the development of end-stage renal disease in diabetes, but which specific circulating inflammatory proteins contribute to this risk remain unknown. To study this, we examined 194 circulating inflammatory proteins in subjects from three independent cohorts with type 1 and type 2 diabetes. In each cohort, we identified an extremely robust kidney risk inflammatory signature (KRIS), consisting of 17 proteins enriched in tumor necrosis factor-receptor superfamily members, that was associated with a 10-year risk of end-stage renal disease. All these proteins had a systemic, non-kidney source. Our prospective study findings provide strong evidence that KRIS proteins contribute to the inflammatory process underlying end-stage renal disease development in both types of diabetes. These proteins point to new therapeutic targets and new prognostic tests to identify subjects at risk of end-stage renal disease, as well as biomarkers to measure responses to treatment of diabetic kidney disease.
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes / M.A. Niewczas, M.E. Pavkov, J. Skupien, A. Smiles, Z.I. Md Dom, J.M. Wilson, J. Park, V. Nair, A. Schlafly, P.-. Saulnier, E. Satake, C.A. Simeone, H. Shah, C. Qiu, H.C. Looker, P. Fiorina, C.F. Ware, J.K. Sun, A. Doria, M. Kretzler, K. Susztak, K.L. Duffin, R.G. Nelson, A.S. Krolewski. - In: NATURE MEDICINE. - ISSN 1078-8956. - 25:5(2019 May), pp. 805-813.
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
P. Fiorina;
2019
Abstract
Chronic inflammation is postulated to be involved in the development of end-stage renal disease in diabetes, but which specific circulating inflammatory proteins contribute to this risk remain unknown. To study this, we examined 194 circulating inflammatory proteins in subjects from three independent cohorts with type 1 and type 2 diabetes. In each cohort, we identified an extremely robust kidney risk inflammatory signature (KRIS), consisting of 17 proteins enriched in tumor necrosis factor-receptor superfamily members, that was associated with a 10-year risk of end-stage renal disease. All these proteins had a systemic, non-kidney source. Our prospective study findings provide strong evidence that KRIS proteins contribute to the inflammatory process underlying end-stage renal disease development in both types of diabetes. These proteins point to new therapeutic targets and new prognostic tests to identify subjects at risk of end-stage renal disease, as well as biomarkers to measure responses to treatment of diabetic kidney disease.File | Dimensione | Formato | |
---|---|---|---|
s41591-019-0415-5.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
1.76 MB
Formato
Adobe PDF
|
1.76 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.